Akebia Historical Income Statement

AKBA Stock  USD 2.06  0.01  0.49%   
Historical analysis of Akebia Ther income statement accounts such as Interest Expense of 9.4 M, Selling General Administrative of 3.1 M or Other Operating Expenses of 300.1 M can show how well Akebia Ther performed in making a profits. Evaluating Akebia Ther income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Akebia Ther's future profits or losses.
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Akebia Ther latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Akebia Ther is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Akebia Ther. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For information on how to trade Akebia Stock refer to our How to Trade Akebia Stock guide.

About Akebia Income Statement Analysis

Akebia Ther Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Akebia Ther shareholders. The income statement also shows Akebia investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Akebia Ther Income Statement Chart

At present, Akebia Ther's Depreciation And Amortization is projected to increase significantly based on the last few years of reporting. The current year's Interest Expense is expected to grow to about 9.4 M, whereas Selling General Administrative is forecasted to decline to about 3.1 M.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Income Before Tax

Income Before Tax which can also be referred as pre-tax income is reported on Akebia Ther income statement and is an important metric when analyzing Akebia Ther profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Akebia Ther minus its cost of goods sold. It is profit before Akebia Ther operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.
Most accounts from Akebia Ther's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Akebia Ther current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Akebia Ther. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For information on how to trade Akebia Stock refer to our How to Trade Akebia Stock guide.At present, Akebia Ther's Depreciation And Amortization is projected to increase significantly based on the last few years of reporting. The current year's Interest Expense is expected to grow to about 9.4 M, whereas Selling General Administrative is forecasted to decline to about 3.1 M.
 2021 2022 2023 2024 (projected)
Interest Expense19.9M15.7M6.0M9.4M
Depreciation And Amortization38.0M35.3M37.6M39.5M

Akebia Ther income statement Correlations

0.730.620.76-0.52-0.530.36-0.390.67-0.56-0.76-0.560.160.820.49-0.560.690.69-0.75-0.280.990.990.33-0.49
0.730.760.76-0.62-0.630.64-0.550.77-0.64-0.43-0.66-0.170.770.57-0.640.50.05-0.4-0.110.750.640.42-0.02
0.620.760.87-0.84-0.860.7-0.820.82-0.87-0.61-0.88-0.610.790.45-0.870.690.21-0.60.060.680.610.420.29
0.760.760.87-0.9-0.90.83-0.840.96-0.91-0.51-0.92-0.380.930.57-0.890.780.3-0.470.150.780.720.51-0.07
-0.52-0.62-0.84-0.91.0-0.770.99-0.831.00.370.990.66-0.69-0.220.99-0.82-0.10.33-0.11-0.55-0.48-0.71-0.2
-0.53-0.63-0.86-0.91.0-0.780.99-0.831.00.391.00.66-0.7-0.240.99-0.83-0.110.35-0.11-0.56-0.49-0.69-0.21
0.360.640.70.83-0.77-0.78-0.780.93-0.76-0.1-0.79-0.480.780.66-0.710.41-0.14-0.020.520.390.290.360.18
-0.39-0.55-0.82-0.840.990.99-0.78-0.780.980.280.980.74-0.61-0.170.97-0.770.00.25-0.16-0.43-0.36-0.69-0.31
0.670.770.820.96-0.83-0.830.93-0.78-0.84-0.39-0.86-0.350.930.7-0.790.60.19-0.330.340.680.610.41-0.06
-0.56-0.64-0.87-0.911.01.0-0.760.98-0.840.431.00.64-0.71-0.240.99-0.84-0.160.4-0.08-0.59-0.53-0.68-0.19
-0.76-0.43-0.61-0.510.370.39-0.10.28-0.390.430.410.04-0.54-0.230.44-0.58-0.80.980.4-0.78-0.82-0.180.2
-0.56-0.66-0.88-0.920.991.0-0.790.98-0.861.00.410.62-0.74-0.280.98-0.83-0.140.38-0.1-0.6-0.53-0.64-0.19
0.16-0.17-0.61-0.380.660.66-0.480.74-0.350.640.040.62-0.140.070.65-0.310.310.04-0.320.10.17-0.51-0.73
0.820.770.790.93-0.69-0.70.78-0.610.93-0.71-0.54-0.74-0.140.78-0.680.610.38-0.50.170.840.790.26-0.19
0.490.570.450.57-0.22-0.240.66-0.170.7-0.24-0.23-0.280.070.78-0.18-0.010.13-0.180.470.50.45-0.12-0.17
-0.56-0.64-0.87-0.890.990.99-0.710.97-0.790.990.440.980.65-0.68-0.18-0.87-0.160.420.0-0.59-0.53-0.72-0.2
0.690.50.690.78-0.82-0.830.41-0.770.6-0.84-0.58-0.83-0.310.61-0.01-0.870.45-0.58-0.330.70.70.57-0.08
0.690.050.210.3-0.1-0.11-0.140.00.19-0.16-0.8-0.140.310.380.13-0.160.45-0.82-0.270.660.770.0-0.6
-0.75-0.4-0.6-0.470.330.35-0.020.25-0.330.40.980.380.04-0.5-0.180.42-0.58-0.820.42-0.77-0.82-0.160.19
-0.28-0.110.060.15-0.11-0.110.52-0.160.34-0.080.4-0.1-0.320.170.470.0-0.33-0.270.42-0.29-0.31-0.10.13
0.990.750.680.78-0.55-0.560.39-0.430.68-0.59-0.78-0.60.10.840.5-0.590.70.66-0.77-0.290.980.32-0.37
0.990.640.610.72-0.48-0.490.29-0.360.61-0.53-0.82-0.530.170.790.45-0.530.70.77-0.82-0.310.980.27-0.49
0.330.420.420.51-0.71-0.690.36-0.690.41-0.68-0.18-0.64-0.510.26-0.12-0.720.570.0-0.16-0.10.320.270.04
-0.49-0.020.29-0.07-0.2-0.210.18-0.31-0.06-0.190.2-0.19-0.73-0.19-0.17-0.2-0.08-0.60.190.13-0.37-0.490.04
Click cells to compare fundamentals

Akebia Ther Account Relationship Matchups

Akebia Ther income statement Accounts

201920202021202220232024 (projected)
Depreciation And Amortization38.6M33.6M38.0M35.3M37.6M39.5M
Interest Expense38.6M8.9M19.9M15.7M6.0M9.4M
Selling General Administrative153.0M157.4M177.7M141.9M3.2M3.1M
Other Operating Expenses621.3M671.7M478.9M355.8M240.9M300.1M
Operating Income(286.3M)(376.4M)(265.3M)(63.2M)(46.3M)(48.6M)
Ebit(286.3M)(376.4M)(265.3M)(78.5M)(44.5M)(46.7M)
Research Development323.0M218.5M147.9M129.1M63.1M59.9M
Ebitda(247.6M)(342.9M)(227.3M)(43.3M)(6.9M)(7.2M)
Total Operating Expenses476.0M375.8M325.5M271.0M166.7M230.4M
Income Before Tax(286.3M)(383.5M)(282.8M)(92.6M)(51.9M)(54.5M)
Total Other Income Expense Net(2K)(7.0M)(17.5M)(13.4M)(5.7M)(5.4M)
Net Income(279.7M)(349.9M)(244.9M)(106.0M)(51.9M)(54.5M)
Income Tax Expense(6.6M)(33.6M)(38.0M)13.4M41.7M43.8M
Total Revenue335.0M295.3M213.6M292.6M194.6M189.1M
Gross Profit189.7M(601K)60.2M207.8M120.5M89.9M
Net Income From Continuing Ops(279.7M)(383.5M)(282.8M)(92.6M)(56.9M)(59.8M)
Cost Of Revenue145.3M295.9M153.4M84.8M74.1M99.1M
Net Income Applicable To Common Shares(279.7M)(383.5M)(282.8M)(92.6M)(83.3M)(87.5M)
Non Operating Income Net Other(794K)1.9M2.4M2.2M2.6M2.7M
Net Interest Income792K(8.9M)(19.9M)(15.7M)(6.3M)(6.6M)
Reconciled Depreciation38.6M33.6M38.0M37.7M37.6M29.6M
Selling And Marketing Expenses149.5M153.9M174.2M3.2M100.2M89.1M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Akebia Ther offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Akebia Ther's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Akebia Ther Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Akebia Ther Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Akebia Ther. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For information on how to trade Akebia Stock refer to our How to Trade Akebia Stock guide.
You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Akebia Ther. If investors know Akebia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Akebia Ther listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.22)
Revenue Per Share
0.834
Quarterly Revenue Growth
(0.11)
Return On Assets
(0.09)
Return On Equity
(5.53)
The market value of Akebia Ther is measured differently than its book value, which is the value of Akebia that is recorded on the company's balance sheet. Investors also form their own opinion of Akebia Ther's value that differs from its market value or its book value, called intrinsic value, which is Akebia Ther's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Akebia Ther's market value can be influenced by many factors that don't directly affect Akebia Ther's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Akebia Ther's value and its price as these two are different measures arrived at by different means. Investors typically determine if Akebia Ther is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Akebia Ther's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.